These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35248788)

  • 1. Tetracyclines and bone: Unclear actions with potentially lasting effects.
    Warner AJ; Hathaway-Schrader JD; Lubker R; Davies C; Novince CM
    Bone; 2022 Jun; 159():116377. PubMed ID: 35248788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G; Critchley I; Lin LY; Alvandi N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance.
    LaPlante KL; Dhand A; Wright K; Lauterio M
    Ann Med; 2022 Dec; 54(1):1686-1700. PubMed ID: 35723082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacy.
    Grada A; Del Rosso JQ; Graber E; Bunick CG; Stein Gold L; Moore AY; Baldwin H; Obagi Z; Damiani G; Carrothers T; McNamee B; Hanze E
    Dermatol Ther; 2022 Mar; 35(3):e15275. PubMed ID: 34923732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists.
    Armstrong AW; Hekmatjah J; Kircik LH
    J Drugs Dermatol; 2020 Nov; 19(11):s6-s13. PubMed ID: 33196746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetracyclines: nonantibiotic properties and their clinical implications.
    Sapadin AN; Fleischmajer R
    J Am Acad Dermatol; 2006 Feb; 54(2):258-65. PubMed ID: 16443056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of sarecycline for the treatment of moderate-to-severe acne vulgaris.
    Valente Duarte de Sousa IC
    Expert Opin Pharmacother; 2021 Feb; 22(2):145-154. PubMed ID: 32924666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarecycline hydrochloride for the treatment of acne vulgaris.
    Kaul G; Saxena D; Dasgupta A; Chopra S
    Drugs Today (Barc); 2019 Oct; 55(10):615-625. PubMed ID: 31720559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Prevalence of Minocycline-Resistant
    Nakase K; Koizumi J; Fukumoto S; Hayashi N; Noguchi N; Nakaminami H
    Microb Drug Resist; 2022 Aug; 28(8):861-866. PubMed ID: 35723664
    [No Abstract]   [Full Text] [Related]  

  • 11. The Development of Third-Generation Tetracycline Antibiotics and New Perspectives.
    Rusu A; Buta EL
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarecycline: A Narrow-Spectrum Antibiotic.
    Adjei S; Miller AC; Temiz LA; Tyring SK
    Skin Therapy Lett; 2022 May; 27(3):5-7. PubMed ID: 35533371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline in acne vulgaris: benefits and risks.
    Ochsendorf F
    Am J Clin Dermatol; 2010; 11(5):327-41. PubMed ID: 20642295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline and Doxycycline: More Than Antibiotics.
    Singh S; Khanna D; Kalra S
    Curr Mol Pharmacol; 2021; 14(6):1046-1065. PubMed ID: 33568043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose minocycline therapy in tetracycline-recalcitrant acne vulgaris.
    Cullen SI
    Cutis; 1978 Jan; 21(1):101-4. PubMed ID: 146595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota.
    Moura IB; Grada A; Spittal W; Clark E; Ewin D; Altringham J; Fumero E; Wilcox MH; Buckley AM
    Front Microbiol; 2022; 13():901911. PubMed ID: 35711781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.
    Griffin MO; Ceballos G; Villarreal FJ
    Pharmacol Res; 2011 Feb; 63(2):102-7. PubMed ID: 20951211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetracycline-, Doxycycline-, Minocycline-Induced Pseudotumor Cerebri and Esophageal Perforation.
    Angelette AL; Rando LL; Wadhwa RD; Barras AA; Delacroix BM; Talbot NC; Ahmadzadeh S; Shekoohi S; Cornett EM; Kaye AM; Kaye AD
    Adv Ther; 2023 Apr; 40(4):1366-1378. PubMed ID: 36763302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li WA
    Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline therapy in acne vulgaris.
    Cullen SI; Cohan RH
    Cutis; 1976 Jun; 17(6):1208-10, 1214. PubMed ID: 138560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.